BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34896061)

  • 21. Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitors.
    Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
    Int J Lab Hematol; 2021 Aug; 43(4):771-778. PubMed ID: 33974363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature.
    Vivaldi P; Rossetti G; Galli M; Finazzi G
    Haematologica; 1997; 82(3):345-7. PubMed ID: 9234588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome.
    Gattorno M; Buoncompagni A; Molinari AC; Barbano GC; Morreale G; Stalla F; Picco P; Mori PG; Pistoia V
    Br J Rheumatol; 1995 Sep; 34(9):873-81. PubMed ID: 7582730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a new silica clotting time for diagnosing lupus anticoagulant in patients who meet the clinical criteria for antiphospholipid syndrome.
    Grypiotis P; Ruffatti A; Pengo V; Tonello M; Biasiolo A; Zamboni D; Cavazzana A; Todesco S
    J Clin Lab Anal; 2006; 20(1):15-8. PubMed ID: 16470527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric systemic lupus erythematosus with lupus anticoagulant hypoprothrombinemia syndrome-A case series with review of literature.
    Kocheril AP; Vettiyil GI; George AS; Shah S; Geevar T; Dave RG; T SK
    Lupus; 2021 Apr; 30(4):641-648. PubMed ID: 33509039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single center review of clinicopathological characterization in 77 patients with positive lupus anticoagulant antibodies.
    Owaidah TM; Qurashi FH; Al Nounou RM; Al Zahrani H; Al Mussa A; Tbakhi AI; Al Daama S; Elkum N; Roberts GT
    Hematology; 2003 Aug; 8(4):249-57. PubMed ID: 12911943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.
    Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD
    Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coagulation Testing in the Core Laboratory.
    Winter WE; Flax SD; Harris NS
    Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?
    Ghirardello A; Doria A; Ruffatti A; Rigoli AM; Vesco P; Calligaro A; Gambari PF
    Ann Rheum Dis; 1994 Feb; 53(2):140-2. PubMed ID: 8129460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Routine Lupus Anticoagulant Sensitive aPTT Testing Can Prevent Unnecessary LA Testing.
    Smit B; Hudig F; Venhuizen JH; Haitjema S; Limper M; Urbanus R; Huisman A
    Clin Appl Thromb Hemost; 2023; 29():10760296231183427. PubMed ID: 37322895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.
    Ząbczyk M; Kopytek M; Natorska J; Undas A
    Clin Chem Lab Med; 2019 Aug; 57(9):1374-1381. PubMed ID: 30763261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Patient with Severe Fever with Thrombocytopenia Syndrome, Activated Partial Thromboplastin Time Prolongation, and Transient Antiphospholipid Antibodies.
    Tsukamoto Y; Sugimoto T; Umeda M; Kato T; Hiura Y; Morita K; Ariyoshi K
    Intern Med; 2023 Jul; 62(14):2145-2149. PubMed ID: 36476549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The varied sensitivity of partial thromboplastin and prothrombin time reagents in the demonstration of the lupus-like anticoagulant.
    Mannucci PM; Canciani MT; Mari D; Meucci P
    Scand J Haematol; 1979 May; 22(5):423-32. PubMed ID: 472662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients.
    Zhu L; Li C; Liu N; Yang X; Jia RL; Mu R; Su Y; Li ZG
    Clin Rheumatol; 2017 Feb; 36(2):401-406. PubMed ID: 28050648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study.
    Chen J; Sun S; Yan Q; Bao C; Fu Q
    Clin Rheumatol; 2016 Feb; 35(2):333-40. PubMed ID: 26753544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lupus anticoagulant and antiphospholipid antibody values in a family with systemic lupus erythematosus].
    Alper G; Tavmergen EN; Ozsan H; Tavmergen E; Gümüsdis G; Onat T; Erlacin E
    Zentralbl Gynakol; 1992; 114(10):509-12. PubMed ID: 1414067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.